The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Cancer‐Associated Fibroblast‐Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression
Abstract
Background and Aims: Cancer‐associated fibroblasts (CAFs) are key players in multicellular, stromal‐dependent alterations leading to HCC pathogenesis. However, the intricate crosstalk between CAFs and other components in the tumor microenvironment (TME) remains unclear. This study aimed to investigate the cellular crosstalk among CAFs, tumor cells, and tumor‐associated neutrophils (TANs) during different stages of HCC pathogenesis. Approach and Results: In the HCC‐TME, CAF‐derived cardiotrophin‐like cytokine factor 1 (CLCF1) increased chemokine (C‐X‐C motif) ligand 6 (CXCL6) and TGF‐β secretion in tumor cells, which subsequently promoted tumor cell stemness in an autocrine manner and TAN infiltration and polarization in a paracrine manner. Moreover, CXCL6 and TGF‐β secreted by HCC cells activated extracellular signal‐regulated kinase (ERK) 1/2 signaling of CAFs to produce more CLCF1, thus forming a positive feedback loop to accelerate HCC progression. Inhibition of ERK1/2 or CLCF1/ciliary neurotrophic factor receptor signaling efficiently impaired CLCF1‐mediated crosstalk among CAFs, tumor cells, and TANs both in vitro and in vivo. In clinical samples, up‐regulation of the CLCF1−CXCL6/TGF‐β axis exhibited a marked correlation with increased cancer stem cells, “N2”‐polarized TANs, tumor stage, and poor prognosis. Conclusions: This study reveals a cytokine‐mediated cellular crosstalk and clinical network involving the CLCF1−CXCL6/TGF‐β axis, which regulates the positive feedback loop among CAFs, tumor stemness, and TANs, HCC progression, and patient prognosis. These results may support the CLCF1 cascade as a potential prognostic biomarker and suggest that selective blockade of CLCF1/ciliary neurotrophic factor receptor or ERK1/2 signaling could provide an effective therapeutic target for patients with HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Self-citationAccessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 1×
“The stromal components of HCC primarily include CAFs, tumorassociated immune cells, and angiogenic cells.(3) CAFs reportedly modulate HCC progression through various mechanisms, including direct effects on cancer cells through the secretion of soluble factors and exosomes and indirect effects through other stromal cel…”
BackgroundPolarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Turning foes to friends: targeting cancer-associated fibroblasts
Chen, X., & Song, E. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0004-1 · Cited by 1,879
JASPAR 2020: update of the open-access database of transcription factor binding profiles
Fornes, O., Castro-Mondragon, J. A., Khan, A., van der Lee, R., Zhang, X., Richmond, P. A., Modi, B. P., Correard, S., Gheorghe, M., Baranašić, D., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1001 · Cited by 1,763
PROMO: detection of known transcription regulatory elements using species-tailored searches
Messeguer, X., Escudero, R., Farré, D., Núñez, O., Martı́nez, J., & Albà, M. M. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.2.333 · Cited by 1,369
Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration
Luga, V., Zhang, L., Viloria-Petit, A. M., Ogunjimi, A. A., Inanlou, M. R., Chiu, E., Buchanan, M., Hosein, A. N., Basik, M., & Wrana, J. L. (2012) · Cell · doi:10.1016/j.cell.2012.11.024 · Cited by 1,311
Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN
Farre, D. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg605 · Cited by 1,036
Neutrophils support lung colonization of metastasis-initiating breast cancer cells
Wculek, S. K., & Malanchi, I. (2015) · Nature · doi:10.1038/nature16140 · Cited by 1,003
The polarization of immune cells in the tumour environment by TGFβ
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H., & Licona-Limón, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2808 · Cited by 940
Zhou, S.-L., Zhou, Z.-J., Hu, Z.-Q., Huang, X.-W., Wang, Z., Chen, E.-B., Fan, J., Cao, Y., Dai, Z., & Zhou, J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.040 · Cited by 852
Self-citationWang, T., Fahrmann, J. F., Lee, H., Li, Y.-J., Tripathi, S. C., Yue, C., Zhang, C., Lifshitz, V., Song, J., Yuan, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.001 · Cited by 825
Self-citationThe Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
Affo, S., Yu, L.-X., & Schwabe, R. F. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100322 · Cited by 757
Purhonen, J., Banerjee, R., McDonald, A. E., Fellman, V., & Kallijärvi, J. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa516 · Cited by 657
Neutrophils in the tumor microenvironment
Powell, D. R., & Huttenlocher, A. (2016) · Trends in Immunology · doi:10.1016/j.it.2015.11.008 · Cited by 578
Ishii, G., Ochiai, A., & Neri, S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.07.007 · Cited by 434
Qin, X., Guo, H., Wang, X., Zhu, X., Yan, M., Wang, X., Xu, Q., Shi, J., Lu, E., Chen, W., et al. (2019) · Genome Biology · doi:10.1186/s13059-018-1604-0 · Cited by 431
Cheng, Y., Li, H., Deng, Y., Tai, Y., Zeng, K., Zhang, Y., Liu, W., Zhang, Q., & Yang, Y. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0458-4 · Cited by 399
Self-citationOct4 and LIF/Stat3 Additively Induce Krüppel Factors to Sustain Embryonic Stem Cell Self-Renewal
Hall, J., Guo, G., Wray, J., Eyres, I., Nichols, J., Grotewold, L., Morfopoulou, S., Humphreys, P., Mansfield, W., Walker, R., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.11.003 · Cited by 383
Navab, R., Strumpf, D., Bandarchi, B., Zhu, C.-Q., Pintilie, M., Ramnarine, V. R., Ibrahimov, E., Radulovich, N., Leung, L., Barczyk, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014506108 · Cited by 364
Ponzetta, A., Carriero, R., Carnevale, S., Barbagallo, M., Molgora, M., Perucchini, C., Magrini, E., Gianni, F., Kunderfranco, P., Polentarutti, N., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.047 · Cited by 255
Zhou, S., Yin, D., Hu, Z., Luo, C., Zhou, Z., Xin, H., Yang, X., Shi, Y., Wang, Z., Huang, X., et al. (2019) · Hepatology · doi:10.1002/hep.30630 · Cited by 226
Self-citationLeca, J., Martinez, S., Lac, S., Nigri, J., Secq, V., Rubis, M., Bressy, C., Sergé, A., Lavaut, M.-N., Dusetti, N., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87734 · Cited by 223
Unique pattern of neutrophil migration and function during tumor progression
Patel, S., Fu, S., Mastio, J., Dominguez, G. A., Purohit, A., Kossenkov, A., Lin, C., Alicea-Torres, K., Sehgal, M., Nefedova, Y., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0229-5 · Cited by 220
Zhu, Y. P., Padgett, L., Dinh, H. Q., Marcovecchio, P., Blatchley, A., Wu, R., Ehinger, E., Kim, C., Mikulski, Z., Seumois, G., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.097 · Cited by 216
Wu, K., Ding, J., Chen, C., Sun, W., Ning, B.-F., Wen, W., Huang, L., Han, T., Yang, W., Wang, C., et al. (2012) · Hepatology · doi:10.1002/hep.26007 · Cited by 204
Neutrophil extracellular traps: protagonists of cancer progression?
Erpenbeck, L., & Schön, M. P. (2017) · Oncogene · doi:10.1038/onc.2016.406 · Cited by 199
Lim, C.-A., Yao, F., Wong, J. J.-Y., George, J., Xu, H., Chiu, K. P., Sung, W.-K., Lipovich, L., Vega, V. B., Chen, J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.038 · Cited by 190
Deng, Y., Cheng, J., Fu, B., Liu, W., Chen, G., Zhang, Q., & Yang, Y. (2017) · Oncogene · doi:10.1038/onc.2016.273 · Cited by 186
Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal
Singel, K. L., & Segal, B. H. (2016) · Immunological Reviews · doi:10.1111/imr.12459 · Cited by 181
Li, T.-J., Jiang, Y.-M., Hu, Y.-F., Huang, L., Yu, J., Zhao, L.-Y., Deng, H.-J., Mou, T.-Y., Liu, H., Yang, Y., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0617 · Cited by 179
Yin, Z., Dong, C., Jiang, K., Xu, Z., Li, R., Guo, K., Shao, S., & Wang, L. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0782-x · Cited by 177
Chen, M.-W., Yang, S.-T., Chien, M., Hua, K., Wu, C., Hsiao, S. M., Lin, H., Hsiao, M., Su, J.-L., & Wei, L. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1115 · Cited by 156
Vicent, S., Sayles, L. C., Vaka, D., Khatri, P., Gevaert, O., Ron, C., Zheng, Y., Gillespie, A. K., Clarke, N., Xu, Y., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1097 · Cited by 136
Cancer-associated fibroblasts promote the stemness of CD24+ liver cells via paracrine signaling
Li, Y., Wang, R., Xiong, S., Wang, X., Zhao, Z., Bai, S., Wang, Y., Zhao, Y., & Cheng, B. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1731-9 · Cited by 101
Self-citationChecks and balances: E2F—microRNA crosstalk in cancer control
Emmrich, S., & Pützer, B. M. (2010) · Cell Cycle · doi:10.4161/cc.9.13.12061 · Cited by 85
Sims, N. A. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.014 · Cited by 57
Liu, G., An, L., Zhang, H., Du, P., & Sheng, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00307 · Cited by 47
Zhao, M., Dong, G., Meng, Q., Lin, S., & Li, X. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29672 · Cited by 41
Burger, R., Bakker, F., Guenther, A., Baum, W., Schmidt‐Arras, D., Hideshima, T., Tai, Y., Shringarpure, R., Catley, L. P., Senaldi, G., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04686.x · Cited by 36
Li, Z., Zhang, Q., Zhang, Q., Xu, M., Qu, Y., Cai, X., & Lu, L. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2015-0136 · Cited by 14
Cited by
Mao, X., Xu, J., Wang, W., Liang, C., Hua, J., Liu, J., Zhang, B., Meng, Q., Yu, X., & Shi, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01428-1 · Cited by 2,290
Cold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 682
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Donne, R., & Lujambio, A. (2023) · Hepatology · doi:10.1002/hep.32740 · Cited by 631
Stromal cells in the tumor microenvironment: accomplices of tumor progression?
Zhao, Y., Shen, M., Wu, L., Yang, H., Yao, Y., Yang, Q., Du, J., Liu, L., Li, Y., & Bai, Y. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-06110-6 · Cited by 431
Self-citationZhang, H., Yue, X., Chen, Z., Liu, C., Wu, W., Zhang, N., Liu, Z., Yang, L., Jiang, Q., Cheng, Q., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01860-5 · Cited by 424
Metadata
- Authors
- Song, M., He, J., Pan, Q., Yang, J., Zhao, J., Zhang, Y., Huang, Y., Tang, Y., Wang, Q., He, J., Gu, J., Li, Y., Chen, S., Zeng, J., Zhou, Z., Yang, C., Han, Y., Chen, H., Xiang, T., Weng, D., & Xia, J.
- Venue
- Hepatology
- Published
- 2021-04-29
- Volume
- 73
- Issue
- 5
- Pages
- 1717-1735
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W3133981801
- Cited by
- 336
- References
- 41
- FWCI
- 24.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.